UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future Directions

Cancers, 2023-07, Vol.15 (14), p.3562

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center

Cancers, 2024-04, Vol.16 (7), p.1428

2024

Link zum Volltext

Verfügbarkeit prüfen

Fair Attribute Classification through Latent Space De-biasing

2021 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2021, p.9297-9306

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions

Journal of gastrointestinal cancer, 2024-03, Vol.55 (1), p.153-167

2024

Link zum Volltext

Verfügbarkeit prüfen

Which grades are better, A’s and C’s, or all B’s? Effects of variability in grades on mock college admissions decisions

Judgment and decision making, 2019-11, Vol.14 (6), p.696-710

2019

Link zum Volltext

Verfügbarkeit prüfen

ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma

Clinical cancer research, 2021-07, Vol.27 (13), p.3641-3648

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

Clinical cancer research, 2020-10, Vol.26 (19), p.5092-5101

2020

Link zum Volltext

Verfügbarkeit prüfen

Information-Theoretic Segmentation by Inpainting Error Maximization

2021 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2021, p.4028-4038

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune Landscape of Epstein–Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution

The Journal of surgical research, 2024-04, Vol.296, p.742-750

2024

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2022-03, Vol.27 (3), p.198-209

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC

BMJ case reports, 2022-08, Vol.15 (8)

2022

Link zum Volltext

Verfügbarkeit prüfen

Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary

Future oncology (London, England), 2024-05, p.1-17

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

Molecular cancer therapeutics, 2022-01, Vol.21 (1), p.227-236

2022

Link zum Volltext

Verfügbarkeit prüfen

Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies

Blood coagulation & fibrinolysis, 2018-03, Vol.29 (2), p.227-230

2018

Link zum Volltext

Verfügbarkeit prüfen

Reduction of Caudate Nucleus Volumes in Neuroleptic-Naïve Female Subjects with Schizotypal Personality Disorder

Biological psychiatry (1969), 2006-07, Vol.60 (1), p.40-48

2006

Link zum Volltext

Verfügbarkeit prüfen

HIVE: Evaluating the Human Interpretability of Visual Explanations

Computer Vision - ECCV 2022, 2022, Vol.13672, p.280-298

2022

Link zum Volltext

Verfügbarkeit prüfen

Overlooked Factors in Concept-Based Explanations: Dataset Choice, Concept Learnability, and Human Capability

2023 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2023, p.10932-10941

2023

Link zum Volltext

Verfügbarkeit prüfen

MO31-4 Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancers

Annals of oncology, 2022-07, Vol.33, p.S502

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b/2, open-label, dose-escalation and expansion trial of tucatinib in combination with trastuzumab with and without oxaliplatin-based chemotherapy or pembrolizumab in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in progress)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS376-TPS376

2022

Link zum Volltext

Verfügbarkeit prüfen

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS257-TPS257

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of early-onset colorectal cancer on utilization of chemotherapy and outcomes in patients with stage II disease

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.85-85

2023

Link zum Volltext

Verfügbarkeit prüfen

Tissue tumor mutational burden (TMB) as a biomarker of efficacy with immune checkpoint inhibitors (ICI) in metastatic gastrointestinal (mGI) cancers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e14559-e14559

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.118-118

2022

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.251-251

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(76)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(86)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future Directions

Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center

Fair Attribute Classification through Latent Space De-biasing

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions

Which grades are better, A’s and C’s, or all B’s? Effects of variability in grades on mock college admissions decisions

ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

Information-Theoretic Segmentation by Inpainting Error Maximization

Immune Landscape of Epstein–Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC

Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary

Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies

Reduction of Caudate Nucleus Volumes in Neuroleptic-Naïve Female Subjects with Schizotypal Personality Disorder

HIVE: Evaluating the Human Interpretability of Visual Explanations

Overlooked Factors in Concept-Based Explanations: Dataset Choice, Concept Learnability, and Human Capability

MO31-4 Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancers

Phase 1b/2, open-label, dose-escalation and expansion trial of tucatinib in combination with trastuzumab with and without oxaliplatin-based chemotherapy or pembrolizumab in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in progress)

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01)

Impact of early-onset colorectal cancer on utilization of chemotherapy and outcomes in patients with stage II disease

Tissue tumor mutational burden (TMB) as a biomarker of efficacy with immune checkpoint inhibitors (ICI) in metastatic gastrointestinal (mGI) cancers

A phase II study of pembrolizumab, binimetinib, and bevacizumab in patients with microsatellite-stable, refractory, metastatic colorectal cancer (mCRC)

Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer

Suchergebnisse filtern